1. Treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure.
2. Treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia who have had an insufficient response to previous treatment (e.g. corticosteroids, immunoglobulins, or splenectomy).